Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Voyager Therapeutics Q2 2024 GAAP EPS $(0.18) Beats $(0.43) Estimate, Sales $29.578M Beat $9.461M Estimate

Author: Benzinga Newsdesk | August 06, 2024 04:10pm
Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.43) by 58.14 percent. The company reported quarterly sales of $29.578 million which beat the analyst consensus estimate of $9.461 million by 212.64 percent. This is a 509.48 percent increase over sales of $4.853 million the same period last year.

Posted In: VYGR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist